Animal models of pheochromocytoma including NIH initial experience

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 300-305

  Ohta, Shoichiro ^a   Lai, Edwin W ^a   Taniguchi, Shun'ichiro ^b   Tischler, Arthur S ^c   Alesci, Salvatore ^d   Pacak, Karel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

17 dimethylamino 17 demethoxygeldanamycin (17 DMAG); Animal model; Pheochromocytoma

Indexed keywords

17 DIMETHYLAMINO 17 DEMETHOXYGELDANAMYCIN; ANTINEOPLASTIC AGENT; CATECHOLAMINE;

CANCER INHIBITION; CARCINOGENESIS; CONFERENCE PAPER; GENETIC ENGINEERING; IMMUNOHISTOCHEMISTRY; NEUROBIOLOGY; NONHUMAN; NUDE MOUSE; PHENOTYPE; PHEOCHROMOCYTOMA; PROTEIN EXPRESSION;

ANIMALIA; MUS MUSCULUS;

EID: 33845501215     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.034     Document Type: Conference Paper

References (15)

1. JOHN, H., W.H. ZIEGLER, D. HAURI, et al. 1999. Pheochromocytomas: can malignant potential be predicted? Urology 53: 679-683.
2. OHTA, S., E.W. LAI, A.L. PANG, et al. 2005. Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int. J. Cancer 114: 139-144.
3. ZIELKE, A.R., S. BRESALIER, A.E. SIPERSTEIN, et al. 1998. A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants. Clin. Exp. Metastasis 16: 341-352.
4. TISCHLER, A.S., J.F. POWER & J. ALROY. 2004. Animal models of pheochromocytoma. Histol. Histopathol. 19: 883-895.
5. SCHULZ, N., F. PROPST, M.M. ROSENBERG, et al. 1992. Patterns of neoplasia in c-mos transgenic mice and their relevance to multiple endocrine neoplasia. Henry Ford Hosp. Med. J. 40: 307-311.
6. SCHULZ, N., F. PROPST, M.P. ROSENBERG, et al. 1992. Pheochromocytomas and C-cell thyroid neoplasms in transgenic cmos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res. 52: 450-455.
7. SMITH-HICKS, C.L., K.C. SIZER, J.F. POWERS, et al. 2000. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J. 19: 612-622.
8. WILLIAMS, B.O., E.M. SCHMITT, L. REMINGTON, et al. 1994. Extensive contribution of Rbdeficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13: 4251-4259.
9. YOU, M.J., D.H. CASTRILLON, B.C. BASTIAN, et al. 2002. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc. Natl. Acad. Sci. USA 99: 1455-1460.
10. POWERS, J.F., M.J. EVINGER, P. TSOKAS, et al. 2000. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res. 302: 309-320.
11. TISCHLER, A.S., W. SHELDON & R. GRAY. 1996. Immunohistochemical and morphological characterization of spontaneously occurring pheochromocytomas in the aging mouse. Vet. Pathol. 33: 512-520.
12. EISENHOFER, G., T.T. HUYNH, K. PACAK, et al. 2004. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr. Relat. Cancer 11: 897-911.
13. BISHT, K.S., C.M. BRADBUR, D. MATTSON, et al. 2003. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res. 63: 8984-8995.
14. BOLTZE, C., H. LEHNERT, R. SCHNEIDER-STOCK, et al. 2003. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma. Endocrine 22: 193-201.
15. HUANG, X., M. DI LIBERTO, A.F. CUNNINGHAM, et al. 2004. Homeostatic cell cycle control by BLyS: induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1. Proc. Natl. Acad. Sci. USA 21: 17789-17794.